The story of Dr. Victor Gurewich illustrates a critical and deeply frustrating tension within the U.S. healthcare system, especially in the realm of treating heart attacks and strokes. Gurewich, a dedicated researcher affiliated with Harvard Medical School since the 1960s, has developed an innovative drug treatment for blood clots that could significantly reduce mortality rates...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
